| Document |
Document Title |
|
WO/2021/028555A1 |
The present invention relates to compostable tools for eating and for drinking, such as drinking straws or cutlery. The present invention furthermore relates to biodegradable medical commodities such as cotton swabs, tongue depressors or...
|
|
WO/2021/025656A1 |
The invention is a purification method required for a dermal filler production process. The object of the invention is to save considerable time and to effectively remove the residual cross-linking agent in the formulation, in contrast t...
|
|
WO/2021/025923A2 |
An insoluble foam composite material is formed by a mixture combining an anionic polysaccharide, a cationic polysaccharide, a solvent, and a plasticizer. In particular, the composite material can be prepared by heating, freezing and lyop...
|
|
WO/2021/019524A1 |
A semirigid packaging, container, or tableware such as spoon, plate, bowl, fork, knife, cup, straw, and the like, with or without lid, uses seaweed as raw material and the manufacturing methode thereof.
|
|
WO/2021/019454A1 |
The present invention relates to gelatins obtained from fish skin, modified with cyclodextrins; to films obtained therefrom; and to the use thereof in the packaging field. In particular, the present invention relates to gelatins obtained...
|
|
WO/2021/015676A1 |
Embodiments of the present invention provide users with a system and method for manufacturing water-based hydrophobic aerogels and aerogel composites. The system and method can be carried out in a manner which is more rapid than typical ...
|
|
WO/2021/012062A1 |
The invention relates to a method for obtaining a homogeneous acidic chitosan–silicon solution that is stable in the short term, provides biopesticidal, biofertiliser and biostimulant properties, systemic acquired resistance (SAR) effe...
|
|
WO/2021/015562A1 |
The present invention relates to a method for preparing a hydrogel composition containing calcium phosphate at a constant content. The hydrogel composition prepared by the method is constant in calcium phosphate content and as such, can ...
|
|
WO/2021/013992A1 |
The application relates to a polymer composition comprising a mixture of: a) a hyaluronic acid polymer at least one carboxylate function of which is grafted with 3-aminophenylboronic acid, and b) a hyaluronic acid polymer at least one ca...
|
|
WO/2021/015588A1 |
The present invention relates to a biocompatible hydrogel comprising hyaluronic acid and polyethylene glycol and, more specifically, to a biocompatible hydrogel, a manufacturing method therefor, and a use thereof, wherein the biocompatib...
|
|
WO/2021/011736A1 |
Amine-functionalized saccharide polymers, including oligosaccharides and polysaccharides, may be effective for promoting clay stabilization in subterranean formations. Oxidative synthesis of amine-functionalized saccharide polymers using...
|
|
WO/2021/007899A1 |
Disclosed is an injectable hydrogel material, which is generated in-situ from component A and component B by means of isovolumetric injection by using dual-linking injection technology; and component A is carboxymethyl chitosan, and comp...
|
|
WO/2021/009248A1 |
Methods of preparing a hemicellulose-product and a holocellulose-product from a carbohydrate-rich material, including spent coffee grounds, are described. Hemicellulose-products and holocellulose-products produced according to these meth...
|
|
WO/2021/006933A1 |
Metal contaminants may be problematic in a number of industries, particularly in the mining industry. Fines production and dust control may be similarly problematic in many industries, including the mining industry. Reaction products for...
|
|
WO/2021/006480A1 |
The present invention relates to a biodegradable composite material prepared by polymerizing an aqueous dispersion of natural polymer nanofibers including any one or more selected from chitin nanofibers and cellulose nanofibers, a dicarb...
|
|
WO/2021/007579A1 |
A novel biodegradable material for use in packaging applications, including food packaging applications, is provided. The disclosed biodegradable material is simple and cost efficient to manufacture, provides a superior water vapor barri...
|
|
WO/2020/264392A1 |
The invention relates to the field of derivatized cross-linked hyaluronic acid hydrogels having blood-derived proteins linked into their structure, as well as preparation and uses thereof.
|
|
WO/2020/259486A1 |
A preparation method for a sericin hydrogel having a self-healing function, comprising: (1) using sericin as a raw material to prepare aminated sericin; (2) using sodium alginate as a raw material to prepare oxidized sodium alginate; (3)...
|
|
WO/2020/260710A1 |
A method is provided for producing a porous graphene or porous graphitic carbon material. The method comprised creating a biopolymer-based feedstock material from a biopolymer formulation (8). The bio polymer is derived from a synthetic ...
|
|
WO/2020/263977A1 |
Films and packaging materials including biodegradable and edible components and pods created using these materials are described herein.
|
|
WO/2020/258152A1 |
A kit comprises: 1) a first composition comprising at least one water insoluble substrate comprising carbon particles, wherein the carbon particles are distributed mainly within the insoluble substrate, and 2) a second composition compri...
|
|
WO/2020/262381A1 |
In this water-soluble hyaluronic acid gel production method, a water-soluble hyaluronic acid gel is provided which can be produced with high productivity and without the need for a step for evaporating a large amount of water from a hyal...
|
|
WO/2020/256287A2 |
The present application pertains to a hydrogel composition containing: a temperature-sensitive polyphosphazene in which a plurality of hydrophobic amino acids, hydrophilic polymers, and host molecules are substituted; and a bioactive sub...
|
|
WO/2020/249143A1 |
Means for use in a preparation of a hydrogel that comprises two separate solutions A and B, of which the solution A comprises enzyme horseradish peroxidase and the solution B comprises hydrogen peroxide, at least one solution A or B comp...
|
|
WO/2020/251947A1 |
A catheter insert device includes a powder composition, and a housing. The powder composition includes a solid phase S-nitrosothiol (RSNO). The housing includes a polymeric wall that is i) permeable to nitric oxide, ii) non-porous, and i...
|
|
WO/2020/250128A1 |
The present invention relates to a method for the production of a cross-linked hyaluronic acid with BDDE (1,4-butanediol diglycidyl ether), to be used in the ophthalmic field, which, unlike what is known, is filterable, and therefore ste...
|
|
WO/2020/251799A1 |
A cell culture article is provided. The cell culture article includes a substrate of a polygalacturonic acid compound crosslinked with a divalent cation, the polygalacturonic acid compound being selected from at least one of: pectic acid...
|
|
WO/2020/245331A1 |
A natural composition for 3D printing comprising alginate from brown seaweed and cellulose nanofibers, wherein the cellulose nanofibers originate from cellulose from the same brown seaweed sample(s) as the alginate.
|
|
WO/2020/246055A1 |
Provided is a binder composition that does not use inorganic acid ions in the raw material therefor, has sufficient reaction speed when causing a crosslinking reaction in the binder, has good dynamic characteristics such as strength and ...
|
|
WO/2020/242396A1 |
The present invention relates to a method for producing chitosan. The method allows the utilization of desert soil. The said soil is reacted with oxalic acid, and chitosan is formed. Obtaining combustible gases using the method disclosed...
|
|
WO/2020/239591A1 |
The present invention relates to a crosslinked carboxyalkyl chitosan forming a matrix, compositions comprising same, a method for manufacturing same, and the different applications thereof, in particular in the field of therapy, rheumato...
|
|
WO/2020/242420A1 |
The present invention relates to the production of cross-linked carboxymethyl cellulose and hyaluronic acid hybrid hydrogel (hybrogel) (100) and its use as a dermal filler in the healthcare industry, particularly in the production of der...
|
|
WO/2020/232539A1 |
A bioresorbable, sustained release pharmaceutical composition comprising: 1.8 wt% to 3.0 wt% methylcellulose and 0.1 wt% to 3.0 wt% hyaluronan in the form of a gel polymer matrix, and at least one local anesthetic agent, suitably ropivac...
|
|
WO/2020/234167A1 |
The invention relates to a printable hydrogel comprising a plurality of microstrands comprising or consisting of a polymer, wherein the microstrands have a diameter of 1 µm to 500 µm and an aspect ratio of at least 100:1, and wherein s...
|
|
WO/2020/232540A1 |
A method of reducing or limiting tissue adhesion comprises contacting the tissue with an effective amount of a hydrogel composition comprising: 2% to 6% by weight hyaluronan, and 3% to 18% by weight methylcellulose, wherein the combined ...
|
|
WO/2020/235991A1 |
The present invention discloses a condensation barrier layer (108) for reducing condensation effect in a food freshness sensor (100) by having a modified kappa-Carrageenan polymer. The k-Carrageenan is modified by way of cross-linking wi...
|
|
WO/2020/229977A1 |
This document provides compositions containing arabinoxylan, methods for making compositions containing arabinoxylan, and methods for using compositions containing arabinoxylan as, for example, a food ingredient, dietary supplement ingre...
|
|
WO/2020/229526A1 |
The invention concerns lyophilized pharmaceutical formulations comprising plasmatic proteins or derivatives thereof, hyaluronic acid or a derivative thereof, and optionally one or more other pharmaceutically active ingredients, such as c...
|
|
WO/2020/228917A1 |
Herein is disclosed an emulsion comprising a silicone pre-elastomer, glycerol, a cyclodextrin, and a metal catalyst suitable for use in the polymerization of the silicone pre-elastomer, a silicone elastomer formed from the emulsion and d...
|
|
WO/2020/230034A1 |
The present invention relates to the use of a bonding resin prepared by providing an aqueous solution comprising at least one biobased product selected from tannin, starch, soy protein, glycerol, chitin, pectin, dextrose or other carbohy...
|
|
WO/2020/227666A1 |
The present disclosure relates to methods for preparing a hydrophilic composition including intimately mixing a silicone component including at least one polysiloxane and a polymer component, and to hydrophobic polymer compositions prepa...
|
|
WO/2020/226476A1 |
A process for obtaining polymer membranes from components of natural origin, which comprise a cross-linked matrix of biomaterials having physical and mechanical properties for controlled loading and release of substances, preferably by m...
|
|
WO/2020/226587A1 |
The present invention relates to biocompatible, biodegradable and bioabsorbable anti-bleeding adhesion barrier membranes that are used to prevent tissue and organ adhesions after surgery and contain hyaluronic acid / chitosan / carboxyme...
|
|
WO/2020/221762A1 |
The invention discloses method for manufacturing agar or agarose beads, comprising the steps of: a) providing a water phase comprising an aqueous solution of agar or agarose at a temperature of 40-100°C; b) providing an oil phase compri...
|
|
WO/2020/209654A1 |
The present invention relates to a hyaluronic acid-based dissolving film, a method for producing same and a release sheet used therefor, and more specifically, to: a method for producing a hyaluronic acid-based dissolving film, whereby a...
|
|
WO/2020/174234A9 |
The invention provides a composition comprising a seaweed extract in an amount of 50-90 % by weight, a water-soluble cellulose derivative in an amount of 10-40 % by weight and water in an amount of 1-20 % by weight, of the total weight o...
|
|
WO/2020/201930A1 |
The present disclosure provides an improved process for the synthesis of sugammadex acid and sugammadex sodium.
|
|
WO/2020/192125A1 |
The present invention relates to a tissue engineering scaffold material, preparation method therefor, application thereof, and application method therefor. The preparation method for a tissue engineering scaffold material comprises: prov...
|
|
WO/2020/188365A1 |
Disclosed are alkenylamides of sulfated hyaluronic acid and their use for the stabilisation and release of medicaments in the form of micellar suspensions which can be administered locally and/or locoregionally, in particular intra-artic...
|
|
WO/2020/186021A1 |
Provided herein is chemically modified, photoactive low molecular weight (LMW) chitin. The photoactive LMW chitin is used to form a variety of biodegradable structures such as films and three-dimensional structures, which can be micropat...
|
